Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma
- 121 Downloads
Recently, XRCC1 polymorphisms were reported to be associated with glioma in Chinese population. However, only a few studies reported on the XRCC1 expression, and cancer progression. In this study, we investigated whether XRCC1 plays a role in glioma pathogenesis. Using the tissue microarray technology, we found that XRCC1 expression is significantly decreased in glioma compared with tumor adjacent normal brain tissue (P < 0.01, χ2 test) and reduced XRCC1 staining was associated with WHO stages (P < 0.05, χ2 test). The mRNA and protein levels of XRCC1 were significantly downregulated in human primary glioma tissues (P < 0.001, χ2 test). We also found that XRCC1 was significantly decreased in glioma cell lines compared to normal human astrocytes (P < 0.01, χ2 test). Overexpression of XRCC1 dramatically reduced the proliferation and caused cessation of cell cycle. The reduced cell proliferation is due to G1 phase arrest as cyclin D1 is diminished whereas p16 is upregulated. We further demonstrated that XRCC1 overexpression suppressed the glioma cell migration and invasion abilities by targeting MMP-2. In addition, we also found that overexpression of XRCC1 sharply inhibited angiogenesis, which correlated with down-regulation of VEGF. The data indicate that XRCC1 may be a tumor suppressor involved in the progression of glioma.
KeywordsXRCC1 Proliferation Migration Invasion Angiogenesis Glioma
This project is supported by grants from the National Natural Science Foundation of China (No.81502160), and Jiangsu Provincial Medical Youth Talent(No.QNRC2016785), and The Project of Invigorating Health Care through Science, Technology and Education (No.CXTDA2017034).
Compliance with ethical standards
Conflict of interest
The authors have declared that no competing interests exist.
This study was performed under a protocol approved by the Institutional Review Boards of The Affiliated Hospital of Xuzhou Medical University.
Informed consent was obtained from all individual participants included in the study.
- 2.Li Y et al (2017) Human fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models. Oncotarget 8(63):106311–106323Google Scholar
- 8.Yin G, Morita M, Ohnaka K, Toyomura K, Hamajima N, Mizoue T, Ueki T, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Terasaka R (2012) Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan. J Epidemiol 22(1):64–71CrossRefGoogle Scholar
- 12.Santonocito C, Scapaticci M, Penitente R, Paradisi A, Capizzi R, Lanza-Silveri S, Ficarra S, Landi F, Zuppi C, Capoluongo E (2012) Polymorphisms in base excision DNA repair genes and association with melanoma risk in a pilot study on central-south Italian population. Clin Chim Acta 413(19–20):1519–1524CrossRefGoogle Scholar
- 20.Sterpone, S. and Cozzi, R. (2010) Influence of XRCC1 Genetic Polymorphisms on Ionizing Radiation-Induced DNA Damage and Repair. J Nucleic Acids 2010Google Scholar
- 29.Hu XB et al (2011) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev 12(11):2981–2984Google Scholar
- 32.Liu QH et al (2017) XRCC1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis through suppressing MMP-2 and MMP-9. Oncotarget 8(65):109382–109392Google Scholar
- 36.Ang MK, Patel MR, Yin XY, Sundaram S, Fritchie K, Zhao N, Liu Y, Freemerman AJ, Wilkerson MD, Walter V, Weissler MC, Shockley WW, Couch ME, Zanation AM, Hackman T, Chera BS, Harris SL, Miller CR, Thorne LB, Hayward MC, Funkhouser WK, Olshan AF, Shores CG, Makowski L, Hayes DN (2011) High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma. Clin Cancer Res 17(20):6542–6552CrossRefGoogle Scholar
- 39.Costello JF et al (1996) Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56(10):2405–2410Google Scholar
- 42.Anderson JC et al (2008) New molecular targets in angiogenic vessels of glioblastoma tumours. Expert Rev Mol Med e23:10Google Scholar
- 44.Guillamo JS, de Bouard S, Valable S, Marteau L, Leuraud P, Marie Y, Poupon MF, Parienti JJ, Raymond E, Peschanski M (2009) Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma. Clin Cancer Res 15(11):3697–3704CrossRefGoogle Scholar